The Potential Benefit of Allogeneic over Autologous Transplantation in Patients with Very Early Relapsed and Refractory Follicular Lymphoma with Prior Remission Duration of ≤ 12 Months

Early relapsed or refractory follicular lymphoma (FL) warrants consolidation with transplantation, though graft source modality remains controversial. We analysed the outcomes of 44 patients transplanted with either autologous or allogeneic graft sources in the post-rituximab era. No difference in e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Haematol
Asıl Yazarlar: Lunning, Matthew A., Migliacci, Jocelyn C., Hilden, Patrick, Devlin, Sean M., Castro-Malaspina, Hugo, Giralt, Sergio, Perales, Miguel-Angel, Zelenetz, Andrew D., Moskowitz, Craig H., Sauter, Craig S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5051568/
https://ncbi.nlm.nih.gov/pubmed/26847389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13947
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller